Eli Lilly’s Retevmo delivers significant gains in event-free survival for early-stage RET fusion-positive NSCLC, marking a breakthrough in targeted lung cancer therapy.
Lupin partners with Spektus Pharma to launch DeslaFlex in Canada, enhancing its CNS portfolio and offering patients a novel treatment option for Major Depressive Disorder.
Courage met opportunity in Haridwar as Akums hosted a three-day skill camp for acid attack and burn survivors, helping them step into corporate life with confidence and purpose.
.png "USFDA Completes Inspection of Enzene Chakan Unit")
The USFDA has completed its inspection of Enzene’s manufacturing unit in Chakan, Pune, issuing six procedural observations with no data integrity issues. The outcome strengthens the company’s compliance standing in regulated markets.
Indian pharma leaders Sun Pharma and Glenmark are adopting AI in drug discovery to reduce costs, accelerate R&D timelines, and move from generics toward innovative medicines.
Entod Pharmaceuticals has introduced Colladerm, the first AI bio-engineered collagen transdermal gel serum, in the 54 th National Conference of Indian Association of Dermatologists
.png "Sanofi Scales Up Hyderabad GCC with Big Investment")
Sanofi Healthcare India has expanded its Hyderabad Global Capability Centre, increasing capacity to 4,500 employees. Backed by a multi-hundred-million-dollar investment, the move strengthens India’s role in Sanofi’s global operations.
.png "Mankind Pharma Completes Global Supply Chain Revamp")
Mankind Pharma has completed a multi-year transformation of its global supply chain and procurement operations, cutting stock-outs by 75% and strengthening medicine access across 25+ international markets with AI-powered planning tools.
Natco Pharma shares jumped nearly 11% after the company received CDSCO approval to manufacture and market generic Semaglutide Injection in India, boosting investor sentiment and driving heavy trading volumes.
.png "Zydus Lifesciences Gets USFDA Nod for Ammonium Lactate Cream")
Zydus Lifesciences has received USFDA approval for Ammonium Lactate Cream, 12%, a treatment for dry skin and ichthyosis vulgaris.
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")